Levocetirizine 5 mg Orodispersible tablet

Levocetirizine 5 mg Orodispersible tablet

Products
Levocetirizine 5 mg Orodispersible tablet
Levocetirizine 5 mg Orodispersible tablet

Information

n Levocetirizine efficacy superior to loratadine, desloratadine and fexofenadine3, 4, 5, 6, 7, 8.n 43% saving on the social cost of persistent allergic rhinitis9.n Minimal impairment of memory and psychomotor functioning nor mood changes after acute and sub chronic administration of levocetirizine10.
All categories
Anatomical Therapeutic Chemical (ATC) Classification ProductsVariousAllergensProducts
Main Categories
Anatomical Therapeutic Chemical (ATC) Classification Products
ATHENAAthena, a French based MNC, is dedicated to developing life-cycle products, with a broad range of technology platforms for oral delivery with a distinctive focus on modified release formulation as well as oro-dispersible dosage forms. Using these technologies Athena has developed a wide range of products in various therapeutic segments like Pain, CNS, Cardiometabolic, Gastroenterology, Gynaecology and more. Athena Pharmaceutiques has two R&D as well as manufacturing units located in Athena IPS, France and Athena DDS, India. Athena is primarily engaged in a Licensing and Supply business model. We can supply products in Finished form as ODT, Tablet, Capsules, Sachets or Semi-finished form as bulk granules for direct compression and pellets for encapsulation/sachets filing. Athena facilities are approved by EU-GMP, Health Canada, TGA- Australia, ANVISA, RUSSIA, SAPHRA and other countries.

Log in

See all the content and easy-to-use features by logging in or registering!